Apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
Patent 6306431 Issued on October 23, 2001. Estimated Expiration Date: April 7, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/449, Transdermal or percutaneous424/402, Wearing apparel, fabric, or cloth424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/447, Bandages with incorporated medicaments424/448, Pressure sensitive adhesive means514/817, ANESTHETIC, TOPICAL514/937, DISPERSION OR EMULSION514/944, GEL602/41, BANDAGE STRUCTURE602/46Polymeric foam
Methods and apparatus for improving administration of drugs through the use of heat and other physical means. The present invention relates to the use of heat and other physical means in conjunction with specially designed dermal drug delivery systems, conventional commercial dermal drug delivery systems, or drugs delivered into a sub-skin depot site via injection and other methods to alter, mainly increase, the drug release rate from the dermal drug delivery systems or the depot sites to accommodate certain clinical needs.
Other References
Arky, et al., Physicians' Desk Reference, 1997, pp. 1336-1340
Mack Publishing Company, "Stability of Pharmaceutical Products," Pharmaceutical Sciences, pp. 1481-1482, 1985
McCafferty, et al., "Comparative In Vivo and In Vitro Assessment of the Percutaneous Absorption of Local Anaesthetics," British Journal of Anaesthesia, vol. 60, (1988), 64-69
Woolfson, et al., "Concentration Response Analysis of Percutaneous Local Anaesthetic Formulations," British Journal of Anaesthesia, vol. 61, (1988), pp. 589-592
McCafferty, et al., "In Vivo Assessment of Percutaneous Local Anaesthetic Preparations," British Journal of Anaesthesia, vol. 62, (1989), pp. 17-21
Knutson et al., "Solvent-Mediated Alterations of the Stratum Corneum," Journal of Controlled Release, vol. 11, (1990), pp. 93-103
Lycka, "EMLA, A New and Effective Topical Anesthetic," J. Dermotol, Surg. Oncol., vol. 18, (1992), pp. 859-862
McCafferty, et al., "New Patch Delivery System for Percutaneous Local Anaesthesia," British Journal of Anaesthesia, vol. 71, (1993) pp. 370-374
Woolfson, Percutaneous Local Anaesthesia, E. Horwood, N.Y. (1993), pp. 166-170
Astra USA, Inc., "EMLA Cream Product Information Form for American Hospital Formulary Service," (1993), pp. 1-28
"Room Temperature," Macmillan, U.S.A., Webster's New World College Dictionary, Third Edition, 1997, p. 1165
Florey, Klaus, Analytical Profiles of Drug Substances, vol. 15, 1986, pp. 150-231
Florey, Klaus, Analytical Profiles of Drug Substances, vol. 12, 1983, pp. 73-105
"Local Anesthetics, Parenteral, General Statement," AHFS Drug Information, 1992
Florey, Klaus, Analytical Profiles of Drug Substances, vol. 18, 1989, pp. 379-411
Sakamoto et al., "Dermal patch anesthesia: comparison of 10% lignocaine gel with absorption promoter and EMLA cream," Anesthesia, (1993), vol. 48, pp. 390-392
Dvoretzky, Israel, M.D., Hyperthermia Therapy for Warts Utilizing a Self-administered Exothermic Patch, Dermal Surgery, (1996), vol. 22, pp. 1035-1039
Stern Peter, M.D. and Levine, Norman, M.D., "Controlled Localized Heat Therapy in Cutaneous Warts," Arch. Dermatol, (Jul. 1992), vol. 128, pp. 945-94
April 7, 2020. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
